lobbying_activities: 3141389

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3141389	a1b89058-6baf-4373-9a92-3148a5742afa	Q1	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2024	first_quarter	MED	* On January 24, ADLM and the American Society for Microbiology wrote to the Centers for Medicare and Medicaid Services requesting that the agency reconsider its decision to recognize a Doctorate in Clincal Laboratory Science as an accepted PhD for high complexity laboratory directors under the CLIA regulations. On March 18, ADLM met with, and submitted comments to, Office of Management and Budget staff in opposition to the release of the Food and Drug Administration final rule on laboratory developed tests. On March 21, ADLM submitted testimony to the House Energy and Commerce Committee Subcommittee on Health raising concerns about FDA oversight of LDTs.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB)		50000	0	0	2024-04-10T13:46:35-04:00